|Articles|October 1, 2004

Quality of life evaluated for patients with AMD

Nashville-Although outcomes data from the Submacular Surgery Trials are not yet available, quality-of-life information from the study will help investigators evaluate the effectiveness of various treatment options for age-related macular degeneration (AMD), said Paul Sternberg Jr., MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME